Structural modification of the propyl linker of cjoc42 in combination with sulfonate ester and triazole replacements for enhanced gankyrin binding and anti-proliferative activity
-
Published:2024-08
Issue:
Volume:110
Page:117836
-
ISSN:0968-0896
-
Container-title:Bioorganic & Medicinal Chemistry
-
language:en
-
Short-container-title:Bioorganic & Medicinal Chemistry
Author:
Chavan Tejashri,
Kanabar Dipti,
Patel Kinjal,
Laflamme Taylor M.,
Riyazi Maryam,
Spratt Donald E.,
Muth AaronORCID
Reference46 articles.
1. Gankyrin drives malignant transformation of chronic liver damage-mediated fibrosis via the Rac1/JNK pathway;Zhao;Cell Death Dis,2015
2. Gradually elevated expression of gankyrin during human hepatocarcinogenesis and its clinicopathological significance;Jing;Sci Rep,2014
3. Reduced stability of retinoblastoma protein by gankyrin, an oncogenic ankyrin-repeat protein overexpressed in hepatomas;Higashitsuji;Nat Med,2000
4. Gankyrin oncoprotein: structure, function, and involvement in cancer;Li;Curr Chem Biol,2010
5. The crystal structure of gankyrin, an oncoprotein found in complexes with cyclin-dependent kinase 4, a 19 S proteasomal ATPase regulator, and the tumor suppressors Rb and P53;Krzywda;J Biol Chem,2004